AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea
· Delayed Price · Currency is KRW 7,100.00
-60.00 (-0.84%)
May 14, 2025, 9:40 AM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 192.47 billion as of May 13, 2025. Its market cap has increased by 44.82% in one year.
Market Cap
192.47B
Enterprise Value
168.48B
Revenue
3.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,100.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 192.47B, a decrease of -54.53%. That is a compound annual growth rate of -12.46%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.02T |
| Celltrion | 33.69T |
| ALTEOGEN | 18.39T |
| Yuhan | 8,026.78B |
| HLB Co., Ltd. | 7,581.42B |
| SK Biopharmaceuticals | 7,079.52B |
| PharmaResearch | 4,171.44B |
| Peptron | 3,872.02B |